![Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome](https://assets.cureus.com/uploads/figure/file/321776/lightbox_8ff44c80810311ecad2ba1a10ca77257-Figure-7.png)
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome
Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score | PLOS ONE
NIKEI: A New Inexpensive and Non-Invasive Scoring System to Exclude Advanced Fibrosis in Patients with NAFLD | PLOS ONE
![Joaquín Primo on Twitter: "HEPAmet Fibrosis Score calculator https://t.co/WNyfiiFNXZ @Dr_Ampuero @mromerogomez @RocioGallegoD @HvrSspa @unisevilla @ibis_sevilla @get_ruben @jturnesv @RegistroHEPAmet @CIBERehd @AEEHLiver @EASLnews #NAFLD #NAFLDresearch ... Joaquín Primo on Twitter: "HEPAmet Fibrosis Score calculator https://t.co/WNyfiiFNXZ @Dr_Ampuero @mromerogomez @RocioGallegoD @HvrSspa @unisevilla @ibis_sevilla @get_ruben @jturnesv @RegistroHEPAmet @CIBERehd @AEEHLiver @EASLnews #NAFLD #NAFLDresearch ...](https://pbs.twimg.com/media/DaubbWjWsAApDmG.jpg)
Joaquín Primo on Twitter: "HEPAmet Fibrosis Score calculator https://t.co/WNyfiiFNXZ @Dr_Ampuero @mromerogomez @RocioGallegoD @HvrSspa @unisevilla @ibis_sevilla @get_ruben @jturnesv @RegistroHEPAmet @CIBERehd @AEEHLiver @EASLnews #NAFLD #NAFLDresearch ...
![HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection](http://www.hcv-trials.com/nash/NAFLD-NASH/big/Diapositive6.jpg)
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease | PLOS ONE
![Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fe1c6cda-f19a-489a-86df-6f889101b716/hepr13688-fig-0002-m.jpg)
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 - Tokushige - 2021 - Hepatology Research - Wiley Online Library
![NAFLD and NASH The next Tsunami in liver disease Are we ready? Mary Pat Pauly MD FACP AASLD Gastroenterology and Liver Disease Kaiser Permanente, Sacramento. - ppt download NAFLD and NASH The next Tsunami in liver disease Are we ready? Mary Pat Pauly MD FACP AASLD Gastroenterology and Liver Disease Kaiser Permanente, Sacramento. - ppt download](https://images.slideplayer.com/47/11728469/slides/slide_38.jpg)
NAFLD and NASH The next Tsunami in liver disease Are we ready? Mary Pat Pauly MD FACP AASLD Gastroenterology and Liver Disease Kaiser Permanente, Sacramento. - ppt download
![Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b90b27221a866f1a2786f6986421c23611d0efdf/3-Table1-1.png)
Table 1 from The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease | Semantic Scholar
![Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD](https://www.oatext.com/img/Non-invasive-3.jpg)
Non-invasive scoring systems for predicting NASH in Japan: evidences from Japan Study Group of NAFLD
![Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome](https://assets.cureus.com/uploads/figure/file/338142/lightbox_82158fd0988b11ec86841deb1a69af7c-Screenshot-2022-02-28-at-16.50.20.png)
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study - ScienceDirect The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0973688322005163-ga1.jpg)
The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study - ScienceDirect
![PDF) Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population PDF) Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population](https://www.researchgate.net/publication/344241572/figure/tbl2/AS:959043438911488@1605665182529/Area-under-the-ROC-curves-of-each-test-according-to-the-stage-of-fibrosis_Q320.jpg)